Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (321-330 of 682) with videos related to

Pageof 69
Sort By:
Neuro-Oncology Advances|June 15, 2022
Pleiotropic <i>MLLT10</i> variation confers risk of meningioma and estrogen-mediated cancersKyle M Walsh, Chenan Zhang, Lisa Calvocoressi, et al.
Cancer Research|March 15, 1993
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locusI J Jacobs, S A Smith, R W Wiseman, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 11, 1992
p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistryB J Kerns, P A Jordan, M B Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance proceduresF J Xu, Y H Yu, L Daly, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinomaEllen Jones, Angeles Alvarez Secord, Leonard R Prosnitz, et al.
British Journal of Cancer|July 16, 2009
MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibitionX Ding, A B Mohd, Z Huang, et al.
International Journal of Cancer|February 1, 1993
Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185F Xu, R Lupu, G C Rodriguez, et al.
Gynecologic Oncology|January 7, 2011
Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cellsDeanna Teoh, Tina A Ayeni, Jennifer M Rubatt, et al.
Gynecologic Oncology|April 3, 2007
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinomaLouis A Dainty, John I Risinger, Carl Morrison, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancerJoellen M Schildkraut, Susan K Murphy, Rachel T Palmieri, et al.
Pageof 69

Showing results (321-330 of 682) with videos related to

Sort By:
Pageof 69
Neuro-Oncology Advances|June 15, 2022
Pleiotropic <i>MLLT10</i> variation confers risk of meningioma and estrogen-mediated cancersKyle M Walsh, Chenan Zhang, Lisa Calvocoressi, et al.
Cancer Research|March 15, 1993
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locusI J Jacobs, S A Smith, R W Wiseman, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 11, 1992
p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistryB J Kerns, P A Jordan, M B Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance proceduresF J Xu, Y H Yu, L Daly, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinomaEllen Jones, Angeles Alvarez Secord, Leonard R Prosnitz, et al.
British Journal of Cancer|July 16, 2009
MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibitionX Ding, A B Mohd, Z Huang, et al.
International Journal of Cancer|February 1, 1993
Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185F Xu, R Lupu, G C Rodriguez, et al.
Gynecologic Oncology|January 7, 2011
Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cellsDeanna Teoh, Tina A Ayeni, Jennifer M Rubatt, et al.
Gynecologic Oncology|April 3, 2007
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinomaLouis A Dainty, John I Risinger, Carl Morrison, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancerJoellen M Schildkraut, Susan K Murphy, Rachel T Palmieri, et al.
Pageof 69